logo

For the Inventor, By the Inventor

Toulouse, France

Centre Hospitalier Universitaire De Toulouse


USPTO Granted Patents = 29


Trademarks = 1

Forward Citations = 9

Loading Chart...
Loading Chart...

108 inventors (with patents filed for the assignee):

goldMedal Thierry Levade (5 out of 5 patents)

silverMedal Bruno Segui (5 out of 5 patents)

bronzeMedal Nathalie Andrieu-Abadie (4 out of 4 patents)

4.  Céline Colacios Viatgé (4 out of 4 patents)

5.  Philippe Valet (4 out of 6 patents)

6.  Florie Bertrand (3 out of 3 patents)

7.  Nicolas Meyer (3 out of 3 patents)

8.  Patricia Martin (3 out of 3 patents)

9.  Eric Oswald (3 out of 4 patents)

10.  Christian Recher (2 out of 2 patents)

11.  Philippe Rochaix (2 out of 2 patents)

12.  Julia Rochotte (2 out of 2 patents)

13.  Antoine Blancher (2 out of 2 patents)

14.  Nicolas Congy (2 out of 2 patents)

15.  Jean-Gerard Tiraby (2 out of 2 patents)


29 patents:

1. 12123000 - Use of PI3KC2B inhibitors for the preservation of vascular endothelial cell barrier integrity (2024-10-22),
2. 12023420 - Vascular stent with antithrombotic properties (2024-07-02),
3. 12011466 - Modifiedstrain Nissle and treatment of gastrointestinal disorder (2024-06-18),
4. 11912645 - Lipopeptide compounds for the treatment of pain disorders (2024-02-27),
5. 11896649 - Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction (2024-02-13),
6. 11623003 - Vaccination against diabetes, obesity and complications thereof (2023-04-11),
7. 11484577 - Methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction (2022-11-01),
8. 11471538 - Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the MAPK pathway (2022-10-18),
9. 11457900 - Microdevice for the in vivo capture of circulating cellular biomarkers (2022-10-04),
10. 11376269 - Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML) (2022-07-05),
11. 11186634 - Antibodies targeting tumor associated macrophages and uses thereof (2021-11-30),
12. 11078277 - Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancer (2021-08-03),
13. 11061037 - Diagnostic of heart failure (2021-07-13),
14. 10918737 - Methods and pharmaceutical composition for the treatment of cancer (2021-02-16),
15. 10822415 - Methods for enhancing the potency of the immune checkpoint inhibitors (2020-11-03),
Centre Hospitalier Universitaire de Toulouse (CHU de Toulouse) is a leading academic hospital located in Toulouse, France. As a university hospital, it serves as a reference center for advanced medical research, education, and patient care. CHU de Toulouse offers a wide range of specialized medical services and treatments across various disciplines. With state-of-the-art facilities and a dedicated team of medical professionals, the hospital strives to provide high-quality healthcare services to its patients.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

29 Patents

#11 in Toulouse

#721 in France

#21,864 in the World

...
Toulouse, France

Centre Hospitalier Universitaire De Toulouse

Forward Citations = 9

108 inventors:

goldMedal Thierry Levade (5 out of 5 patents)

silverMedal Bruno Segui (5 out of 5 patents)

bronzeMedal Nathalie Andrieu-Abadie (4 out of 4 patents)

4.  Céline Colacios Viatgé (4 out of 4 patents)

5.  Philippe Valet (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…